CANNTAB THERAPEUTICS (CTABF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 17 250 sessions, September 6, 2023 to September 6, 2024
- Largest daily move
- +356.3% close of March 13, 2024
- 1-year change
- -98.7% closing prices, September 6, 2023 to September 6, 2024
Company Description
CANNTAB THERAPEUTICS (OTC: CTABF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $147.0K.
CTABF has declined 98.7% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for CTABF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CANNTAB THERAPEUTICS (CTABF) closed at $0.0001 on September 6, 2024. Over the past 12 months, the price has lost 98.7%.
CTABF Metrics & Rankings
Price returns through September 6, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CANNTAB THERAPEUTICS has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include management, private placement. View all CTABF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CTABF Company Profile & Sector Positioning
CANNTAB THERAPEUTICS (CTABF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CTABF often look at related companies in the same sector, including CENTR BRANDS CORP (CNTRF), XEBRA BRANDS LTD (XBRAF), PINEAPPLE EXPRES CANNABIS (PNXP), VIADERMA INC (VDRM), and CRYOMASS TECHNOLOGIES INC (CRYM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CTABF's relative position within its industry.